wellrank.ai
Sign In

Zepbound vs Wegovy: which works better and which is easier to get online?

ClaudecomparisonCollected Jul 22, 2026, 09:42 UTC

Verbatim response from Claude

Zepbound vs Wegovy: Quick Comparison

Which Works Better?

Zepbound (tirzepatide) has the edge in clinical trials.

  • Zepbound: Average weight loss of ~20-22% of body weight in trials
  • Wegovy (semaglutide): Average weight loss of ~15% of body weight

Zepbound works on two hormone receptors (GIP + GLP-1) vs Wegovy's one (GLP-1 only), which likely explains the stronger results. That said, individual responses vary significantly.


Which Is Easier to Get Online?

Both are widely available through telehealth, but it depends on what you mean:

For Brand Name:

  • Hims & Hers, Ro, and Noom Med prescribe both
  • Wegovy has historically had better supply consistency

For Compounded versions (cheaper, easier access):

  • Hims & Hers and Ro offer compounded semaglutide (Wegovy-equivalent)
  • LifeMD and Henry offer compounded tirzepatide (Zepbound-equivalent)
  • ⚠️ Note: FDA has signaled compounded GLP-1s may face restrictions as shortages resolve

Bottom Line

  • Best results: Zepbound
  • Easiest/cheapest online access: Compounded semaglutide through Hims & Hers or Ro
  • Budget brand option: Check Mark Cuban's Cost Plus Drugs for pricing

Always consult a doctor to determine what's right for you.

Brands mentioned in this answer

Is this answer wrong about your brand?

AI engines repeat outdated pricing, wrong ingredients, and misread positioning every day. Tell us what this answer gets wrong and we will include a correction review in your free AI Visibility Audit.

This answer is reproduced verbatim from the engine's API at collection time and may contain errors or outdated claims. It is presented as evidence of what AI engines tell buyers, not as medical or purchasing advice.

Is your brand missing from this answer?

Get your AI Visibility Audit: every buyer intent question you are losing, who wins them, and the sources that decide the answer.